FD&C BLUE NO. 2

Substance profile for UNII L06K8R7DQK, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII: L06K8R7DQK
Preferred term: FD&C BLUE NO. 2
Registry number: 860-22-0
Ingredient type: INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI: 0
PubChem: 0
NCIt: C71675
INN ID: 0

Open Chemistry Sources#

Source, Identifier, Link table
Source	Identifier	Link
NCI Thesaurus	C71675	https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71675
FDA Substance Registration System	L06K8R7DQK	https://precision.fda.gov/uniisearch/srs/unii/L06K8R7DQK

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	GLIMEPIRIDE	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	NAPROXEN Tablets, USP NAPROXEN SODIUM Tablets, USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ESZOPICLONE	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	AZITHROMYCIN	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ETODOLAC	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ZOLPIDEM TARTRATE	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	DOCUSATE SODIUM AND SENNA	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	LEVETIRACETAM	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	GLIMEPIRIDE	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	LISINOPRIL AND HYDROCHLOROTHIAZIDE	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ZONISAMIDE	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	14db4981-5e50-4551-84f0-24f2c833d629	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ALPRAZOLAM	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Drug Facts	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use Gabapentin capsules safely and effectively. See full prescribing information for gabapentin capsules. Gabapentin Capsules, USP for oral use Initial U.S. Approval: 1993	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	L-METHYLFOLATE CALCIUM 7.5mg Tablets L-METHYLFOLATE CALCIUM 15mg Tablets	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	MORPHINE SULFATE	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Zonisamide	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use valacyclovir tablets, USP safely and effectively. See full prescribing information for valacyclovir tablets, USP. VALACYCLOVIR TABLETS USP Initial U.S. Approval: 1995	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	DIVALPROEX SODIUM	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ESZOPICLONE	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	doxepin hydrochloride	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Alprazolam Tablets, USP	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	LAMOTRIGINE	1
FD&C Blue No. 2	INACTIVE INGREDIENT	L06K8R7DQK	Metolazone Tablets, USP	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use memantine hydrochloride safely and effectively. See full prescribing information for memantine hydrochloride. MEMANTINE hydrochloride tablets, for oral use Initial U.S. Approval: 2003	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules (MAS-ER) safely and effectively. See full prescribing information for MAS-ER Capsules. Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules (mixed salts of a single-entity amphetamine product), CII Initial U.S. Approv	17
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA® (sildenafil citrate) tablets, for oral use Initial U.S. Approval: 1998	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use phentermine hydrochloride capsules, USP safely and effectively. See full prescribing information for phentermine hydrochloride capsules, USP. PHENTERMINE Hydrochloride Capsules, USP CIV Initial U.S. Approval: 1959	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	344f908c-934e-4c98-aeef-68fd09d47c72	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Somnapure Clinical Strength	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Levothyroxine Sodium Tablets, USP	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Levothyroxine Sodium Tablets, USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use oxybutynin chloride extended-release tablets safely and effectively. See full prescribing information for oxybutynin chloride extended-release tablets. Oxybutynin Chloride Extended-Release Tablets for oral use Initial U.S. Approval: 1975	1001
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Triamterene and Hydrochlorothiazide Tablets USP Revised: April 2012 Rx only	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use zolpidem tartrate tablets, USP safely and effectively. See full prescribing information for zolpidem tartrate tablets, USP ZOLPIDEM Tartrate Tablets, USP, for oral use CIV Initial U.S. Approval: 1992	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Hydrochlorothiazide Capsules, USP Revised: October 2011 Rx only 174788-3	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Hydrochlorothiazide Capsules, USP Revised: October 2011 Rx only 174788-3	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Naproxen Sodium Tablets, USP 275 mg and 550 mg	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Ursodiol Capsules, USP	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	DOXYCYCLINE HYCLATE TABLETS, USP Rev. 11/14 Rx Only	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Niva-Plus™ Tablets	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Pilocarpine Hydrochloride Tablets, USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	PROCHLORPERAZINE MALEATE TABLETS USP Rx Only	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Tamsulosin hydrochloride capsules USP, 0.4 mg These highlights do not include all the information needed to use Tamsulosin hydrochloride safely and effectively. See full prescribing information for Tamsulosin hydrochloride. Tamsulosin hydrochloride (Tamsulosin hydrochloride) CAPSULE for ORAL use. Initial U.S. Approval: 1997	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	DOXYCYCLINE HYCLATE CAPSULES, USP	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE. RISPERIDONE TABLETS USP, for oral use Initial U.S. Approval: 1993	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 1999	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 1997	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Drug Facts	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Cold-EEZE ® Daytime/Nighttime QuickMelts ®	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Naproxen Sodium Tablets, USP 275 mg and 550 mg	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Cyclobenzaprine Hydrochloride Tablets, USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ALPRAZOLAM TABLETS, USP CIV	2
FD&C Blue No. 2	INACTIVE INGREDIENT	L06K8R7DQK	Children's Pain Relief	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	392476e1-49fd-4014-bb52-b31937077c33	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	b4189b86-b109-4828-9bcb-38e9dbc248db	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Rx only	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	SELECT-OB ® Prenatal Supplement	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	AMITRIPTYLINE HYDROCHLORIDE TABLETS, USP	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Falessa Kit	5
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Isotretinoin Capsules USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROXYZINE PAMOATE CAPSULES USP	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	dalan Therapy liquid antibacterial hand soap ANTIBACTERIAL & odor neutralizer	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	SELECT-OB ® Chewable Caplets Prenatal Supplement	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Unknown Title	1000
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use divalproex sodium extended-release tablets USP safely and effectively. See full prescribing information for divalproex sodium extended-release tablets USP. DIVALPROEX Sodium Extended-Release Tablets USP, for Oral Use Initial U.S. Approval: 2000	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY (aripiprazole) Tablets ABILIFY DISCMELT (aripiprazole) Orally Disintegrating Tablets ABILIFY (aripiprazole) Oral Solution ABILIFY (aripiprazole) Injection FOR INTRAMUSCULAR USE ONLY Initial U.S. Approval: 2002 ® ® ® ®	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY (aripiprazole) Tablets ABILIFY DISCMELT (aripiprazole) Orally Disintegrating Tablets ABILIFY (aripiprazole) Oral Solution ABILIFY (aripiprazole) Injection FOR INTRAMUSCULAR USE ONLY Initial U.S. Approval: 2002 ® ® ® ®	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	LOSARTAN POTASSIUM TABLETS USP R x only	5
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use Omeprazole delayed-release capsules safely and effectively. See full prescribing information for Omeprazole delayed-release capsules. OMEPRAZOLE delayed-release capsules, USP, for oral use Initial U.S. Approval: 1989	23
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use FLUOXETINE CAPSULES USP safely and effectively. See full prescribing information for FLUOXETINE CAPSULES USP. FLUOXETINE capsules USP for oral use Initial U.S. Approval: 1987	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use duloxetine delayed-release capsules safely and effectively. See full prescribing information for duloxetine delayed-release capsules. DULOXETINE delayed-release capsules for oral use. Initial U.S. Approval: 2004	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	rOPINIRole Tablets USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	6368bb69-43e9-4304-a30d-03d593c1c05f	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	AMITRIPTYLINE HYDROCHLORIDE TABLETS, USP Rx only	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX. CHANTIX® (varenicline) Tablets Initial U.S. Approval: 2006	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX. CHANTIX® (varenicline) Tablets Initial U.S. Approval: 2006	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	718b6ebd-279e-4de0-ad46-c1d2a25ed19d	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Probenecid Tablets, USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	be67ff48-8e43-4589-800b-7c67d0c36cea	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	efbc79b9-c07c-40e3-ad8b-9bced4c93aa5	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Drug Facts	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ACETAMINOPHEN AND DIPHENHYDRAMINE HCL TABLETS	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Amitriptyline Hydrochloride Tablets, USP	5
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	BuPROPion Hydrochloride Tablets, USP	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	BuPROPion Hydrochloride Tablets, USP	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	PROPRANOLOL HYDROCHLORIDE TABLETS USP Rx only	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Cyclobenzaprine Hydrochloride Tablets, USP	5
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Sertraline Tablets, USP 50 mg Iss. 09/12 Rx Only	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets. Carvedilol Tablets, USP for oral use Initial U.S. Approval: 1995	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Warfarin Sodium Tablets, USP Crystalline	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Warfarin Sodium Tablets, USP Crystalline	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	SYNTHROID® (levothyroxine sodium tablets, USP)	5
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Tamsulosin hydrochloride capsules USP, 0.4 mg These highlights do not include all the information needed to use Tamsulosin hydrochloride safely and effectively. See full prescribing information for Tamsulosin hydrochloride. Tamsulosin hydrochloride (Tamsulosin hydrochloride) CAPSULE for ORAL use. Initial U.S. Approval: 1997	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Alprazolam Tablets, USP	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (Duloxetine Delayed-Release Capsules) for Oral Use. Initial U.S. Approval: 2004	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use zolpidem tartrate tablets safely and effectively. See full prescribing information for zolpidem tartrate tablets Zolpidem Tartrate Tablets, for oral use CIV Initial U.S. Approval: 1992	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets ABILIFY DISCMELT ® (aripiprazole) Orally Disintegrating Tablets ABILIFY ® (aripiprazole) Oral Solution ABILIFY ® (aripiprazole) Injection FOR INTRAMUSCULAR USE ONLY Initial U.S. Approval: 2002	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	3859effa-7b9b-41cd-9c90-847fa99e9b34	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	4ac590e9-af71-43c0-a836-b700115d7ba2	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Metoprolol Tartrate Tablets USP Rx Only Prescribing Information	7
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	SYNTHROID® (levothyroxine sodium tablets, USP)	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1997 budesonide capsules (enteric coated) budesonide capsules (enteric coated) BUDESONIDE capsules (enteric coated), for oral use	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	LOSARTAN POTASSIUM TABLETS USP R x only	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Divalproex Sodium Delayed Release Tablets USP	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ACYCLOVIR CAPSULES USP ACYCLOVIR TABLETS USP Rx only	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use STRATTERA safely and effectively. See full prescribing information for STRATTERA. STRATTERA (atomoxetine) CAPSULES for Oral Use Initial U.S. Approval: 2002 ®	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use STRATTERA safely and effectively. See full prescribing information for STRATTERA. STRATTERA (atomoxetine) CAPSULES for Oral Use Initial U.S. Approval: 2002 ®	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use STRATTERA safely and effectively. See full prescribing information for STRATTERA. STRATTERA (atomoxetine) CAPSULES for Oral Use Initial U.S. Approval: 2002 ®	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use STRATTERA safely and effectively. See full prescribing information for STRATTERA. STRATTERA (atomoxetine) CAPSULES for Oral Use Initial U.S. Approval: 2002 ®	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	d4adaa46-062e-4c1e-9d9c-e7073463a40d	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	SERTRALINE HYDROCHLORIDE Tablets and Oral Concentrate	8
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Doxycycline Hyclate Tablets, USP	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	Sertraline Hydrochloride Tablets 25 mg, 50 mg and 100 mg	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	These highlights do not include all the information needed to use warfarin sodium safely and effectively. See full prescribing information for warfarin sodium. Warfarin Sodium Tablets USP, for oral use Initial U.S. Approval: 1954	1

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date
FD&C BLUE NO. 2	Golden State Medical Supply, Inc. \| Lannett Company, Inc.	2026-06-02
FD&C BLUE NO. 2	PD-Rx Pharmaceuticals, Inc.	2026-05-28
FD&C BLUE NO. 2	AvPAK	2026-05-28
FD&C BLUE NO. 2	PD-Rx Pharmaceuticals, Inc.	2026-05-27
FD&C BLUE NO. 2	BluePoint Laboratories \| LUPIN LIMITED	2026-05-27
FD&C BLUE NO. 2	A-S Medication Solutions	2026-05-27
FD&C BLUE NO. 2	PD-Rx Pharmaceuticals, Inc.	2026-05-27
FD&C BLUE NO. 2	Coupler LLC \| Lupin Atlantis Holdings SA	2026-05-27
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-27
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-26
FD&C BLUE NO. 2	Coupler LLC	2026-05-26
FD&C BLUE NO. 2	Coupler LLC	2026-05-26
FD&C BLUE NO. 2	Coupler LLC	2026-05-26
FD&C BLUE NO. 2	Camber Pharmaceuticals, Inc. \| Annora Pharma Private Limited	2026-05-25
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-22
FD&C BLUE NO. 2	Preferred Pharmaceuticals, Inc.	2026-05-22
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-22
FD&C BLUE NO. 2	Redpharm Drug	2026-05-22
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-21
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-21
FD&C BLUE NO. 2	Zydus Lifesciences Limited	2026-05-21
FD&C BLUE NO. 2	Florida Pharmaceutical Products, LLC \| INDOCO REMEDIES LIMITED	2026-05-21
FD&C BLUE NO. 2	BluePoint Laboratories \| Unichem Laboratories Ltd	2026-05-21
FD&C BLUE NO. 2	PD-Rx Pharmaceuticals, Inc.	2026-05-21
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-21
FD&C BLUE NO. 2	Pfizer Laboratories Div Pfizer Inc \| Pfizer Inc \| Viatris Pharmaceuticals LLC \| Pharmacia & Upjohn Company LLC \| Pfizer Ireland Pharmaceuticals Unlimited Company \| Pfizer Manufacturing Deutschland GmbH	2026-05-21
FD&C BLUE NO. 2	Coupler LLC	2026-05-21
FD&C BLUE NO. 2	Preferred Pharmaceuticals Inc.	2026-05-21
FD&C BLUE NO. 2	Mylan Pharmaceuticals Inc. \| Pfizer Inc \| Pharmacia & Upjohn Company LLC \| Pfizer Italia S.r.l.	2026-05-21
FD&C BLUE NO. 2	Zydus Pharmaceuticals (USA) Inc.	2026-05-21
FD&C BLUE NO. 2	Prasco Laboratories \| Pfizer Inc \| Pfizer Manufacturing Deutschland GmbH \| Pharmacia & Upjohn Company LLC \| Pfizer Ireland Pharmaceuticals Unlimited Company \| Pfizer Asia Manufacturing Pte Ltd	2026-05-21
FD&C BLUE NO. 2	BluePoint Laboratories \| Aurobindo Pharma Limited	2026-05-20
FD&C BLUE NO. 2	Preferred Pharmaceuticals Inc.	2026-05-20
FD&C BLUE NO. 2	Preferred Pharmaceuticals, Inc.	2026-05-20
FD&C BLUE NO. 2	AvPAK	2026-05-20
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-20
FD&C BLUE NO. 2	Preferred Pharmaceuticals Inc.	2026-05-20
FD&C BLUE NO. 2	PD-Rx Pharmaceuticals, Inc.	2026-05-20
FD&C BLUE NO. 2	AvKARE	2026-05-20
FD&C BLUE NO. 2	Strides Pharma Science Limited \| Strides Pharma Global Pte. Ltd.	2026-05-20
FD&C BLUE NO. 2	Amici Pharma, Inc.	2026-05-20
FD&C BLUE NO. 2	ST. MARY'S MEDICAL PARK PHARMACY	2026-05-20
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-19
FD&C Blue No. 2	Dr. Reddy's Laboratories Inc \| Dr. Reddy’s Laboratories SA \| Mayne Pharma International Pty Ltd	2026-05-19
FD&C BLUE NO. 2	St. Mary's Medical Park Pharmacy \| St Mary's Medical Park Pharmacy	2026-05-19
FD&C BLUE NO. 2	Rising Pharma Holdings, Inc. \| Aurobindo Pharma Limited	2026-05-19
FD&C BLUE NO. 2	ST. MARY'S MEDICAL PARK PHARMACY	2026-05-19
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-19
FD&C BLUE NO. 2	Reckitt Benckiser LLC	2026-05-19
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-18
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-18
FD&C BLUE NO. 2	Preferred Pharmaceuticals Inc.	2026-05-18
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-18
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-18
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-18
FD&C BLUE NO. 2	Preferred Pharmaceuticals, Inc.	2026-05-18
FD&C BLUE NO. 2	TIME CAP LABORATORIES, INC	2026-05-18
FD&C BLUE NO. 2	NuCare Pharmaceuticals, Inc.	2026-05-18
FD&C BLUE NO. 2	Amneal Pharmaceuticals of New York LLC \| Anderson Packaging, Inc \| Purdue Pharmaceuticals L.P. \| Sharp Packaging Solutions	2026-05-15
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-15
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-15
FD&C BLUE NO. 2	Amerisource Bergen	2026-05-15
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-14
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-14
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-14
FD&C BLUE NO. 2	Cardinal Health 107, LLC	2026-05-14
FD&C BLUE NO. 2	ST. MARY'S MEDICAL PARK PHARMACY	2026-05-14
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-14
FD&C BLUE NO. 2	Bryant Ranch Prepack	2026-05-14
FD&C BLUE NO. 2	PD-Rx Pharmaceuticals, Inc.	2026-05-13
FD&C BLUE NO. 2	Rhodes Pharmaceuticals LLC \| Knoa Pharmaceuticals LLC	2026-05-13
FD&C BLUE NO. 2	Macleods Pharmaceuticals Limited	2026-05-13
FD&C BLUE NO. 2	Umedica Laboratories USA Inc. \| UMEDICA LABORATORIES PRIVATE LIMITED	2026-05-13
FD&C BLUE NO. 2	Coupler LLC \| Lupin Atlantis Holdings SA	2026-05-13
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-13
FD&C BLUE NO. 2	Major Pharmaceuticals	2026-05-13
FD&C BLUE NO. 2	Reckitt Benckiser LLC	2026-05-13
FD&C BLUE NO. 2	REMEDYREPACK INC.	2026-05-12
FD&C BLUE NO. 2	Reckitt Benckiser LLC	2026-05-12
FD&C BLUE NO. 2	UCB, Inc.	2026-05-12

FD&C BLUE NO. 2

Substance Identity#

Chemical And Database Identifiers#

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Related DailyMed Labels#